Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
Article in Journal of Experimental & Clinical Cancer Research (September 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Journal of Experimental & Clinical Cancer Research (September 2024)
Article in Science Advances (August 2024)
Article in IUBMB Life (July 2024)